| Name | Title | Contact Details |
|---|---|---|
Chris Jones |
Chief Technology Officer and Chief Data Officer | Profile |
Systems Evolution, Inc. (SEI) is a business and technology consulting firm committed to delivering superior value to local clients since 1992. We pair cutting-edge technologies with custom-tailored solutions to drive powerful business results for some of the most influential companies in the world. We offer the agility, consistency, and personal attention of a local partner while providing the reach and knowledge assets of a national organization. SEI supports critical client needs in areas including Data & Analytics, Technology Enablement, Strategy & Operations, Concept to Delivery, and Security, Risk and Compliance. A 100% employee-owned business, SEI now employs hundreds of consultants across the United States. Our value proposition to both clients and employees is based on a unique business model focused on local delivery, empowerment through technology, fully customized approaches and solutions, and a culture of collaboration.
Aiwyn helps leading accounting firms automate and optimize critical revenue processes by unlocking client data from existing practice management and CRM systems with our Practice Automation platform. With Aiwyns Practice Automation platform, high-value firm executives, partners, and staff are liberated to deliver more value to clients and work at the highest end of their professional expertise. Benefits of Practice Automation to accounting firms include: - save time, bill faster - eliminate tedious back office tasks - reduce days-in-WIP and days-in-AR, - speed up client payments - smooth out cash flow - protect financial health with predictive insights and controls - offer a best-in-class experience to both employees and clients
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Zurn Elkay Water Solutions supplies the industrys widest range of clean water solutions for drinking water, hygiene and sustainable water management. Headquartered in Milwaukee, Wisconsin, Zurn Elkay works with customers around the globe to deliver products and systems that enhance and ensure water quality, safety, hygiene, flow control and conservation. From healthcare to hospitality, education to retail and residential to office facilities, we pride ourselves on meeting specialized needs for every market, focusing on quality, reliability, quick installation and easy maintenance. Our values of Continuous Improvement, Integrity in Everything We Do, Customer First, Culture of Winning, and Total Associate Engagement serve as our drive to achieve world-class safety, quality, delivery, cost and growth now and in the future. In everything we do, we are sustainably inspired. We work to make our communities better with volunteerism and philanthropy, and support diversity, equity and inclusion inside and outside our walls. We seek to uphold our promise to the planet every day by providing sustainable water management solutions.
The WSAVA represents more than 200,000 veterinarians worldwide through its 110 member associations and works to enhance standards of clinical care for companion animals. Its core activities include the development of WSAVA Global Guidelines in key areas of companion animal veterinary practice and lobbying on important issues affecting companion animal care worldwide.